altimmune glp 1 ($ALT): Best-in-Class Tolerability, One Real Fibrosis Question, and a Serious-Liver-Disease Franchise the Market Is Pricing at Almost Nothing GLP-1s and Alcohol? Altimmune Just

(Pilot study: Obesity Pillars)

After a two-year-long shortage, the FDA announced that Eli Lillys GLP-1 drug Mounjaro, and obesity version Zepbound, are back in stock.

Starting today, eligible Medicare patients living with obesity can access Wegovy (semaglutide) injection and pill for a $50 monthly copay Wegovy offers...

Health Canada's January 21 advisory tells buyers to verify GLP-1 drugs via eight-digit DIN and Drug Product Database, and flags CBSA cooperation on shipments.

Autoimmune thyroid disease (AITD), including Hashimoto thyroiditis and Graves disease, represents the most prevalent organ-specific autoimmunity and a major cause of thyroid dysfunction worldwide

20122014 Expanded Therapeutic Options The approvals of Qsymia, Belviq, Contrave, and Saxenda broadened the treatment landscape and reinforced obesity as a chronic disease requiring evidence-based medical management